A drug to treat coronavirus patients, developed by the DRDO (Defence Research and Development Organisation), has been approved for emergency use by the country's top drugs controller as India battles the second wave of the pandemic that is killing thousands every day.
The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
A DRDO lab and Hyderabad-based Dr Reddy's Laboratories developed the anti-Covid therapeutic application of the drug 2-deoxy-D-glucose (2-DG).
The Drugs Controller General of India (DCGI) cleared the drug after clinical trial results showed that a molecule present in the drug helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
A higher proportion of patients treated with the drug tested negative for Covid in RT-PCR tests.
In the second phase of trials between May and October last year, the drug was found to be safe in COVID-19 patients and showed significant improvement in their recovery. The second round was conducted in 110 patients. While the third round of trials was conducted in six hospitals, "dose ranging" was conducted in 11 hospitals across India.
Massive international help has been pouring in as India reports shortage of essential drugs, medical oxygen and other supplies needed for Covid patients after the the sudden surge in COVID-19 cases crippled the country's healthcare system.
India on Saturday recorded 4,187 coronavirus deaths, the highest daily count so far, even as more and more states imposed lockdowns in a desperate bid to halt the devastating new surge. Over 4.01 lakh new infections pushed the total caseload to over 2.18 crore.
From FLiRT To FLuQE: What To Know About The Latest Covid Variants Covid Still Kills 1,700 A Week Around World: WHO Light Tanks, Developed In 2 Years, Unveiled. Will Be Deployed Against China 3 Students Dead After Flooding In Delhi Coaching Centre Basement At Olympics Opening Ceremony, Drag Parody Of 'The Last Supper' Draws Flak Kamala Harris Cuts Down Donald Trump's Lead Sharply, Show Latest Polls Will Quit Politics If Attempts Are Made To Disturb Reservation: Praful Patel DSSSB Exam Schedule 2024 Released For Recruitment To Various Posts AAP's Atishi Calls For Meeting After Delhiites Complain Of Blue Tap Water Track Latest News Live on NDTV.com and get news updates from India and around the world.